Normally, CTLA-4 inhibits T cells at the initial stage of naïve T-cell activation in the early stages of the immune cycle in the lymph nodes [16, 17], while PD-1 regulates previously activated T cells at the later stages of an immune response in the peripheral tissues or at the tumor site [17]. This evidence concerns the gene CTLA4 and neoplasm.